TMCnet News
Boston Therapeutics Taps Dr. Meng Hee Tan as Consulting Medical Director [Health & Beauty Close - Up](Health & Beauty Close - Up Via Acquire Media NewsEdge) Boston Therapeutics said that it has appointed Meng Hee Tan, M.D. to serve as its Consulting Medical Director. In its release, the Company said that Dr. Tan is a professor of internal medicine at the University of Michigan and attending physician in metabolism, endocrinology and diabetes at the University of Michigan Health System. A member of the American Diabetes Association and the American College of Endocrinology, he is the author or coauthor of more than 110 peer-reviewed publications in the area of diabetes and carbohydrate metabolism. He is a past senior medical director of the Diabetes Endocrine Platform Team at Eli Lilly and Company. Dr. Tan said, "The need for innovative treatments in diabetes has never been greater, in light of the increasing numbers of Americans with this disease. I believe Boston Therapeutics is doing valuable and innovative work in this area, and I am looking forward to helping guide the Company's development of its diabetes-related treatments." David Platt, Chief Executive Officer of Boston Therapeutics, said, "We are extremely fortunate to have attracted Dr. Meng Hee Tan to serve as our Consulting Medical Director. His decades of leadership in the field of diabetes research will be a significant asset to us as we continue to seek the best path forward to helping those with diabetes." More Information and Complete Details: www.bostonti.com ((Comments on this story may be sent to [email protected])) (c) 2014 ProQuest Information and Learning Company; All Rights Reserved. |